Evidence map›Paper›PMID 42530669›Full record

ArticlePlanta2026

Functional characterization of a novel flavonoid glycosyltransferase UGT89AD6 from Anemarrhena asphodeloides Bunge and mechanistic insights into its enzymatic O-glycosylation.

Qian Zhang, Qiongyu Ye, Guangli Li, Xiaoyun Wang, Yidu Chen, Zishu Dong, Qimeng Fan, Zhixin Li, Liangshan Ming, Hongning Liu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qian Zhang *Institute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Qiongyu Ye *School of Pharmaceutical Sciences, Guangzhou Huali College, Jiangmen, 529100, China.
Guangli LiDepartment of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
Xiaoyun Wang *Research Center for Traditional Chinese Medicine Resources and Ethnic Minority Medicine, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Yidu ChenRegenex Pharmaceuticals Ltd., Guangzhou, 510670, China.
Zishu DongInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Qimeng FanInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Zhixin LiInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Liangshan MingInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Hongning LiuInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China. 19820002@jxutcm.edu.cn.
Jia HuangInstitute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, 330004, China. huangjia@jxutcm.edu.cn.

Funding

Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education 2060302Doctoral Research Start-up Fund Project of Jiangxi University of Chinese Medicine 2022BSZR001Jiangxi Provincial Natural Science Foundation 20242BAB20452Science Technology Plan Project of Jiangxi Provincial Health Commission 202311138
6 · The paper itself

Abstract

MAIN

conclusionUGT89AD6 is a versatile O-glycosyltransferase with broad substrate and sugar donor promiscuity, offering a valuable biocatalyst for flavonoid glycoside synthesis. Anemarrhena asphodeloides Bunge, known as a famous monocotyledonous medicinal plant in China, contains a typically important secondary metabolite icariside I with various pharmacological activities. In A. asphodeloides, icariside I is derived from the O-glycosylation of icaritin. However, the O-glycosyltransferase from A. asphodeloides catalyzing the glycosylation of icaritin remains largely unidentified. Herein, a promiscuous O-glycosyltransferase UGT89AD6 from A. asphodeloides was successfully identified and characterized. It exhibited catalytic activity toward icaritin, thereby forming the glycosylated product icariside I. It also showed broad glycosylation activities toward other structurally diverse substrates, including eight other flavonoid compounds and an anthraquinone scaffold. Furthermore, it could accept four UDP-sugars as the donors; the preference order was UDP-Xyl > UDP-Glc > UDP-Rha > UDP-Ara. Structural analysis indicated that the broad O-glycosylation activities of UGT89AD6 could be linked to the unique spacious substrate binding pocket. Beyond this, the regioselectivity of UGT89AD6 might be shaped by hydrophobic interactions and hydrogen-bonding network, as well as shallow cavity of the binding pocket. This study contributes to the diversity of glycosyltransferases from monocotyledonous plants and provides a potential biocatalyst to synthesize high-value bioactive flavonoid glycosides.

Indexed as

AnemarrhenaFlavonoidsGlycosyltransferasesPlant ProteinsGlycosylationSubstrate SpecificityUridine Diphosphate SugarsFlavonoidsGlycosyltransferasesPlant ProteinsUridine Diphosphate SugarsBiosynthesisFlavonoid glycosidesGlycosylationPlant enzymologySubstrate promiscuity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.